Recent 8-K filings for PRCT

• April 29, 2026, 7:59 PM ET earnings materiality 0.60 neutral item 2.02item 9.01 ◈ Earnings Releases

  PROCEPT BioRobotics Reports Q1 2026 Revenue of $83.1M, Up 20% YoY; Net Loss Widens to $31.6M

  Total revenue $83.1M, +20% YoY; U.S. procedures 12,200, +30% YoY.

• March 6, 2026, 6:59 PM ET leadership materiality 0.35 neutral item 5.02item 9.01

  Appoints Daniel Puckett as new board member and Audit Committee member

  Board expanded from 8 to 9 members; Puckett appointed effective March 5, 2026.

• February 26, 2026, 6:59 PM ET other material materiality 0.20 neutral item 7.01item 9.01

  PROCEPT BioRobotics holds Investor Day; no specific data disclosed in 8-K exhibit excerpt

  Investor Day held Feb 26, 2026 at NASDAQ HQ; presentation furnished as Exhibit 99.1.

• February 25, 2026, 6:59 PM ET earnings materiality 0.75 neutral item 2.02item 9.01

  PROCEPT BioRobotics Q4 rev $76.4M (+12% YoY), net loss $29.8M; FY26 guidance $390-410M

  Q4 total revenue $76.4M (+12% YoY); U.S. procedures ~12,200 (+69% YoY).

• November 4, 2025, 6:59 PM ET earnings materiality 0.80 positive item 2.02item 9.01

  PROCEPT Q3 revenue $83.3M (+43% YoY); issues FY2026 guidance $410M-$430M

  Q3 total revenue $83.3M, up 43% YoY; U.S. handpiece/consumables $44.4M (+50% YoY).

• September 18, 2025, 7:59 PM ET other material materiality 0.45 neutral item 5.02item 9.01

  PROCEPT BioRobotics modifies severance for non-CEO execs: severance doubled to 12 months, lump sum on change of control

  Severance period for non-CEO execs increased from 6 to 12 months for termination without cause not tied to a change of control.

• August 6, 2025, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01

  PROCEPT Q2 revenue $79.2M (+48% YoY); raises FY25 guidance; appoints new CEO

  Q2 total revenue $79.2M, up 48% YoY; U.S. handpiece/consumables $43.1M (+58%).

• July 25, 2025, 7:59 PM ET leadership materiality 0.75 positive item 2.02item 5.02item 7.01item 9.01

  PROCEPT BioRobotics appoints Larry Wood as CEO, pre-announces Q2 revenue of $79.2M (+48% YoY)

  Larry L. Wood becomes President and CEO effective Sept 2, 2025; succeeds Reza Zadno who retires.

• June 11, 2025, 7:59 PM ET other materiality 0.15 neutral item 5.07

  Procept BioRobotics stockholders elect directors, ratify auditor, approve say-on-pay

  Directors elected: Little (31.8M votes for), Prescott (41.7M), Wood (39.8M); broker non-votes 4.35M.

• April 25, 2025, 7:59 PM ET other material materiality 0.05 neutral item 7.01item 9.01

  Procept BioRobotics presents at AUA investor event; no financial details in filing excerpt

  Company furnished presentation slides for AUA annual meeting on April 25, 2025.

• April 24, 2025, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01

  PROCEPT BioRobotics Q1 revenue up 55% to $69.2M; raises FY2025 guidance to $323M

  Total revenue $69.2M, +55% YoY; U.S. revenue $60.3M (+50%); international $8.9M (+104%).

• February 25, 2025, 6:59 PM ET earnings materiality 0.85 positive item 2.02item 9.01

  PROCEPT BioRobotics Q4 revenue up 57% to $68.2M; guides FY2025 revenue ~$320M (+42%)

  Q4 rev $68.2M (+57% YoY); US system rev $27.6M (+67%); handpiece rev $29.3M (+36%).

• October 31, 2024, 7:59 PM ET other material materiality 0.60 neutral item 8.01item 9.01

  PROCEPT BioRobotics issues ~1.92M shares at $91/share, nets ~$163.8M in public offering

  Company sold 1,923,076 shares at $91 per share; net proceeds to company were ~$163.8M after discounts and expenses.

• October 28, 2024, 7:59 PM ET earnings materiality 0.85 positive item 2.02item 9.01

  PROCEPT BioRobotics Q3 revenue $58.4M (+66% YoY); raises 2024 revenue and EBITDA guidance

  Q3 revenue $58.4M, up 66% YoY; U.S. handpiece+consumables $29.6M (+74%).

• August 21, 2024, 7:59 PM ET regulatory materiality 0.65 positive item 8.01

  PROCEPT BioRobotics receives FDA 510(k) clearance for HYDROS Robotic System

  HYDROS features FirstAssist AI for AI-powered treatment planning using real-world procedure data.

• August 1, 2024, 7:59 PM ET earnings materiality 0.85 positive item 2.02item 9.01

  PROCEPT BioRobotics Q2 revenue $53.4M (+61% YoY); raises FY2024 revenue and EBITDA guidance

  Total revenue $53.4M (+61% YoY); U.S. handpiece & consumables $27.3M (+101% YoY).

• July 19, 2024, 7:59 PM ET leadership materiality 0.50 neutral item 5.02item 9.01 ◈ executive_change ×2

  Director Krummel resigns; Thomas M. Prescott appointed new board member and chairperson

  Dr. Thomas Krummel resigned from Board and Compensation Committee effective July 18, 2024; no disagreement with company.

• June 5, 2024, 7:59 PM ET other materiality 0.00 neutral item 5.07

  Procept BioRobotics shareholders elect three directors, ratify auditor, approve executive compensation at annual meeting

  Amy Dodrill, Taylor Harris, and Reza Zadno elected to board with majority vote.

• May 3, 2024, 7:59 PM ET other material materiality 0.10 neutral item 7.01item 9.01

  PROCEPT BioRobotics furnishes investor presentation; no specific financial data disclosed

  Company will present at investor conferences starting May 3, 2024, using slides furnished as Exhibit 99.1.

• May 1, 2024, 7:59 PM ET earnings materiality 0.30 neutral item 2.02item 9.01 ◈ Earnings Releases

  PROCEPT BioRobotics announces Q1 2024 earnings; press release not included in filing

  The 8-K filing references a press release dated May 1, 2024 for Q1 2024 financial results.

• April 19, 2024, 7:59 PM ET leadership materiality 0.30 neutral item 5.02item 9.01

  Director Colby Wood resigns; Larry Wood appointed to board and audit committee

  Colby Wood resigned as director and Audit Committee member effective April 18, 2024; no disagreement cited.

Executive changes

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.85 · Median 0.60 · Most common event earnings

8 positive 0 negative 13 neutral

source · PRCT on sec.gov